Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Helena Bragadottir"'
Autor:
Magnus Johannsson, V. Asgrimsson, B.O. Rafnar, Andres Magnusson, Steinn Steingrimsson, I. Snorradottir, Helena Bragadottir, H.M. Haraldsson, Engilbert Sigurdsson, Gudrun Dora Bjarnadottir
Publikováno v:
Drug and alcohol dependence. 178
Background and aims Methylphenidate (MPH) is a prescription stimulant used to treat attention-deficit hyperactivity disorder. MPH is currently the preferred substance among most intravenous (i.v.) substance users in Iceland. Four types of MPH prepara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb2175bc1695e992512193e55248bb6
https://pubmed.ncbi.nlm.nih.gov/28651152
https://pubmed.ncbi.nlm.nih.gov/28651152
Autor:
Bjarni O. Rafnar, Andres Magnusson, Gudrun Dora Bjarnadottir, Magnus Johannsson, Engilbert Sigurdsson, Steinn Steingrimsson, Helena Bragadottir, H. Magnus Haraldsson
Publikováno v:
European addiction research. 22(5)
Background/Aims: Methylphenidate (MPH) has been the most commonly used intravenous (i.v.) substance in Iceland in recent years. In Iceland, MPH is available in 3 forms: immediate-release (IR) tablets (MPH IR, short-acting), sustainable-release (SR) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52627d0904f0af130f9f474660c8fc1
https://pubmed.ncbi.nlm.nih.gov/27287610
https://pubmed.ncbi.nlm.nih.gov/27287610
Autor:
Steinn Steingrimsson, Haraldur Magnus Haraldsson, Bjarni O. Rafnar, Andres Magnusson, Engilbert Sigurdsson, Helena Bragadottir, Gudrun Dora Bjarnadottir, Magnus Johannsson
Publikováno v:
Journal of Addiction Medicine
Prescriptions of methylphenidate (MPH) for attention-deficit/hyperactivity disorder (ADHD) have been rising sharply in most Western countries during the past decade (Scheffler et al., 2007; Dalsgaard et al., 2012). This rise in MPH use has been parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26dfc2bda563955b36086e12ec98ca29
https://pubmed.ncbi.nlm.nih.gov/25748561
https://pubmed.ncbi.nlm.nih.gov/25748561
Autor:
Engilbert Sigurdsson, Helena Bragadottir, Gudrun Dora Bjarnadottir, Andres Magnusson, Steinn Steingrimsson, Magnús Haraldsson, B.O. Rafnar
Publikováno v:
European Psychiatry. 28:1
Background Prescription and sale of Methylphenidate (MPD) has increased sharply in Iceland in recent years as it has done worldwide. MPD is known to have abuse potential but significant i.v. use of prescription stimulants has not been reported in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc67e7781b5f05351e9566d7d23a5b7a
https://doi.org/10.1016/s0924-9338(13)75928-5
https://doi.org/10.1016/s0924-9338(13)75928-5